Allied Market Research

Postpartum Hemorrhage (PPH) Devices Market Is Expected to Reach $906 Million by 2022 Supported by a CAGR of 5.2% During the Forecast Period 2016 to 2022

The study provides an in-depth analysis of the global postpartum hemorrhage devices market, with current trends and future estimations, to elucidate the imminent investment pockets. The report provides a quantitative analysis from 2014 to 2022, which is expected to enable the stakeholders to capitalize on prevailing market opportunities

 

Portland, OR -- (SBWIRE) -- 06/22/2018 -- Post-partum Hemorrhage (PPH) Devices Market Report, published by Allied Market Research, was valued at $637 million in 2015, and is expected to garner $906 million by 2022, registering a CAGR of 5.2% during the period 2016 – 2022.The Uterine balloon tamponade is expected to remain the highest revenue-generating segment throughout the forecast period.

Access Report Summary: https://www.alliedmarketresearch.com/post-partum-hemorrhage-devices-market

The factors that are expected to drive the growth of the PPH market are: increasing incidence of pregnancy related complications, such as multiple pregnancies, inverted uterus, and large baby size; increasing risk factors which cause PPH, such as uterine atony, trauma, retained placenta, and bleeding disorders; and technological advancements in the recently approved devices. However, the lack of trained professionals and healthcare services in developing countries hamper the market growth.

In Uterine balloon tamponade segment, Foley Catheter is projected to grow fastest with a CAGR of 7.8%, as they are cost effective devices. On the other hand, Bakri balloon tamponade is expected to be the highest revenue generating segment in the PPH devices as they can be easily used in low resource settings and is effective in stopping hemorrhage.

Get Sample Copy of this Research Report Here : https://www.alliedmarketresearch.com/request-sample/1676

Uterine balloon tamponade accounted for a major share in the world PPH devices in 2015, and is expected to maintain this trend throughout the forecast period. This is attributed to the rise in the prevalence of PPH cases, increasing awareness among women regarding postpartum hemorrhage and presence of advanced healthcare facilities in developed countries. However, Asia-Pacific is expected to be the fastest growing region throughout the analysis period, owing to presence of ample growth opportunities in terms of unmet medical needs for the treatment of PPH cases and high rate of anemia among pregnant women in the region.

South Korea is one of the attractive markets in the global postpartum hemorrhage devices market. Increasing healthcare expenditure and better focus on the development of cost-effective PPH preventive devices have led to its increased market potential for the postpartum hemorrhage devices in the country. Rising number of cases of pregnancy related cases and increasing risk factors causing postpartum hemorrhage are driving the growth of this market. Thus, South Korea is a potential and emerging market for growth of postpartum hemorrhage products.

PPH devices MARKET KEY BENEFITS
-The study provides an in-depth analysis of the global postpartum hemorrhage devices market, with current trends and future estimations, to elucidate the imminent investment pockets
-The report provides a quantitative analysis from 2014 to 2022, which is expected to enable the stakeholders to capitalize on prevailing market opportunities
-The report provides actual historical figures for 2014 and Y-o-Y forecasts from 2016 to 2022, considering 2015 as base.
-Competitive intelligence highlights the business practices followed by leading players across various regions
-Comprehensive analysis of all geographic regions are provided to determine the prevailing opportunities in these geographies.
Extensive analysis of the market is conducted by closely following key product positioning and monitoring the top contenders within the market framework

In North America, Mexico was the fastest growing region in 2015 and is projected to grow at a CAGR of 13.7% during the period. The U.S. on the other hand was the highest revenue generating country of the region. In Europe, Italy was the fastest growing country during the forecast period while Germany was the top revenue generating country of the region. China was the highest revenue generating country of the Asia-Pacific region. While in LAMEA region, Brazil was the highest revenue generating segment.

The key players profiled in this report include Utah Medical Products, Inc., C. R. Bard, Inc., Cook Medical, Inc., Becton, Dickinson, and Company, Teleflex Incorporated, Bactiguard AB, Program for Appropriate Technology in Health (PATH), 3RD Stone Design, Inc., Zoex Niasg, Vitality Medical. Revmedx Inc. and Inpress Technologies.

Enquiry Here: https://www.alliedmarketresearch.com/purchase-enquiry/1676